Abiopharma

🔍 HAINES KATHLEEN C (Executive)

Company: GENCO SHIPPING & TRADING LTD (GNK)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 427 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 14,160.63 | transaction_form_type: 4 | Footnotes: F1, F13, F2, F2
• Acquired 242 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,018.54 | transaction_form_type: 4 | Footnotes: F1, F13, F3, F3
• Acquired 501 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,623.86 | transaction_form_type: 4 | Footnotes: F1, F13, F4, F4
• Acquired 661 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,903.46 | transaction_form_type: 4 | Footnotes: F1, F13, F5, F5
• Acquired 255 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,464.63 | transaction_form_type: 4 | Footnotes: F1, F13, F6, F6
• Acquired 200 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,617.72 | transaction_form_type: 4 | Footnotes: F1, F13, F7, F7
• Acquired 276 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,163.06 | transaction_form_type: 4 | Footnotes: F1, F13, F8, F8
• Acquired 204 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,772.84 | transaction_form_type: 4 | Footnotes: F1, F13, F9, F9
• Acquired 297 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,851.45 | transaction_form_type: 4 | Footnotes: F1, F13, F10, F10
• Acquired 95 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,156.34 | transaction_form_type: 4 | Footnotes: F1, F13, F10, F10
• Acquired 172 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,717.47 | transaction_form_type: 4 | Footnotes: F1, F13, F11, F11
• Acquired 64 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,117.89 | transaction_form_type: 4 | Footnotes: F1, F13, F12, F12

Footnotes:

• F1: Each restricted stock unit ("RSU") represents the right to receive one share of the issuer's common stock, or in the sole discretion of the issuer's Compensation Committee, the value of a share of common stock on the date that the restricted stock unit vests.
• F2: These RSUs vested on May 15, 2018.
• F3: These RSUs vested on May 15, 2019.
• F4: These RSUs vested on July 15, 2020.
• F5: These RSUs vested on May 13, 2021.
• F6: These RSUs vested on May 16, 2022.
• F7: These RSUs vested on May 16, 2023.
• F8: These RSUs vested on May 23, 2024.
• F9: These RSUs vested on May 20, 2025.
• F10: These RSUs vested on June 18, 2026.
• F11: Represents RSUs granted annually to independent directors generally. These RSUs generally vest on the earlier of (i) the date of the annual shareholders meeting of the issuer next following the June 18, 2026 grant date and (ii) August 18, 2027 (the date that is fourteen months after the grant date).
• F12: Represents RSUs granted annually in connection with the Reporting Person's service as Lead Independent Director of the Issuer's Board of Directors. These RSUs generally vest on the earlier of (i) the date of the annual shareholders meeting of the issuer next following the June 18, 2026 grant date and (ii) August 18, 2027 (the date that is fourteen months after the grant date).
• F13: Represents additional RSUs granted in lieu of the right to receive the amount of cash dividends paid on the common stock underlying the previously outstanding RSUs pursuant to the terms of the governing RSU agreements. The number of additional RSUs is calculated by dividing the amount of the dividend by the 30-trading day trailing volume-weighted average price per share of the issuer's common stock on the dividend payment date.